URO TODAY: Brachytherapy involving permanent insertion of radioactive seeds is giving excellent long-term results with prostate cancer patients, regardless of disease severity, a 12-year study has found. READ MORE>
At 12 years, biochemical failure and cause-specific mortality were 1.8% and 0.2%, 5.1% and 2.1%, and 10.4% and 7.1% for Gleason scores 5 to 6 and 7 and >/=8, respectively.
These results are echoed by a Canadian study. READ MORE>
And a Serbian study adds further similar information. READ MORE>